New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
08:02 EDTMELAMELA Sciences announces pending one-for-ten reverse stock split
MELA Sciences announced that its board has approved a one-for-ten reverse stock split of the company's common stock to become effective at 5 p.m., Eastern Time, July 9. The company will file an amendment to its Certificate of Incorporation on that date as authorized by the stockholders at the company's annual meeting held on May 15. The company's common stock is expected to commence trading on a post-reverse stock split basis on July 10. The common stock will continue to trade under the symbol "MELA." The reverse stock split is intended to increase the per share trading price of the company's common stock to satisfy the $1.00 minimum bid price requirement for continued listing on the NASDAQ Capital Market.
News For MELA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 23, 2015
09:14 EDTMELAOn The Fly: Pre-market Movers
Subscribe for More Information
08:43 EDTMELAMELA Sciences to host business news update conference call
Conference call to be held on June 23 at 8:30 am. Webcast Link
08:07 EDTMELAMELA Sciences acquires XTRAC, VTRAC business from PhotoMedex for $42.5M
MELA Sciences announced that it has signed and completed the purchase of the XTRAC and VTRAC Dermatology business from PhotoMedex, Inc. for $42.5M in cash and the assumption of certain business-related liabilities. The purchase price includes all of the accounts receivable, inventory and fixed and intangible assets of the businesses. To fund the purchase price of the transaction, the company has issued senior secured notes and convertible debentures equal to the transaction purchase price to certain investors. The XTRAC and VTRAC businesses generated $30.6M in revenues in 2014.
08:05 EDTMELAPhotoMedex sells XTRAC, VTRAC businesses to MELA for $42.5M in cash
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use